Trial intelligence / Profile preview

Effect of adding dexmedetomidine to ropivacaine and bupivacaine on pain and shivering in lower limb orthopedic patients

IRCT20130926014779N6Phase 2Completed

Sponsor
Jahrom University of Medical Sciences
Start
Dec 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised trial of dexmedetomidine in postoperative pain and postanesthetic shivering (PAS) (2 arms), sponsored by Jahrom University of Medical Sciences. Primary endpoints: Pain intensity and Postoperative shivering. Started Dec 2019; status: completed.

02

Drugs

dexmedetomidine
03

Conditions

postoperative painpostanesthetic shivering (PAS)

Beyond the preview

Go deeper on IRCT20130926014779N6.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20130926014779N6.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call